170402 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving growth factors Nerve growth factor [NGF]
METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#2METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#3METHOD FOR THE EARLY DIAGNOSIS OF NEURODEGENERATIVE DISEASES BY MEANS OF QUANTIFICATION OF PRONGF AND DERIVED FORMS THEREOF
#4RECOMBINANT CHO CELL, CONSTRUCTION METHOD THEREFOR, AND DETECTION SYSTEM AND METHOD USING SAME
#5ANTI-HUMAN NERVE GROWTH FACTOR ANTIBODY
#6Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASD
#7Method and kit for use in inhiiting tumor progression, predicting or determining tumor progression state in VGF expressing cancers
#8Biomarker and methods for early diagnosis of Alzheimer's disease
#9HUMAN ANTI-NGF NEUTRALIZING ANTIBODIES AS SELECTIVE NGF PATHWAY INHIBITORS
#10Use of acamprosate to modulate ERK1/2 activation in animal models for FXS and ASD and individuals diagnosed with FXS and ASD
#11Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#12Modulation sAPP, sAAPα and BDNF levels in individuals diagnosed with FXS and ASD
#13BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#14PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#15Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF
#16Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#17DIFFERENTIAL DIAGNOSTIC BIOMARKERS OF STROKE MIMICKING CONDITIONS AND METHODS OF USE THEREOF
#18Method for prongf assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of prongf
#19INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA
#20Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors
#21Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
#22Ninjurin-1 modulation and uses thereof
#23Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#24Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
#25Method for ProNGF assay for in vitro diagnosis of cancer in particular breast, thyroid or lung cancer and therapeutic use of ProNGF
#26Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
#27Methods for the prediction of arrhythmias and prevention of sudden cardiac death
#28Methods of screening for modulators of nerve growth factor
#29Method for NGF assay for in vitro diagnosis of breast cancer and therapeutic use
#30Stimulation of nerve cell regeneration
#31Methods of diagnosing or treating Alzheimer's disease on basis of increased cerebrospinal fluid levels of nerve growth factor
#32Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors